Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials
Publication
, Conference
Young, JB; Swedberg, K; Dunlap, ME; Pfeffer, MA; Probstfield, JL; Granger, CB; McKelvey, RS; McMurray, JJV; Michaelson, EL; Olofsson, B ...
Published in: Journal of Cardiac Failure
August 2004
Duke Scholars
Published In
Journal of Cardiac Failure
DOI
ISSN
1071-9164
Publication Date
August 2004
Volume
10
Issue
4
Start / End Page
S76 / S76
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Young, J. B., Swedberg, K., Dunlap, M. E., Pfeffer, M. A., Probstfield, J. L., Granger, C. B., … Yusuf, S. (2004). Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. In Journal of Cardiac Failure (Vol. 10, pp. S76–S76). Elsevier BV. https://doi.org/10.1016/j.cardfail.2004.06.212
Young, James B., Karl Swedberg, Mark E. Dunlap, Marc A. Pfeffer, Jeffrey L. Probstfield, Christopher B. Granger, Robert S. McKelvey, et al. “Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials.” In Journal of Cardiac Failure, 10:S76–S76. Elsevier BV, 2004. https://doi.org/10.1016/j.cardfail.2004.06.212.
Young JB, Swedberg K, Dunlap ME, Pfeffer MA, Probstfield JL, Granger CB, et al. Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. In: Journal of Cardiac Failure. Elsevier BV; 2004. p. S76–S76.
Young, James B., et al. “Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials.” Journal of Cardiac Failure, vol. 10, no. 4, Elsevier BV, 2004, pp. S76–S76. Crossref, doi:10.1016/j.cardfail.2004.06.212.
Young JB, Swedberg K, Dunlap ME, Pfeffer MA, Probstfield JL, Granger CB, McKelvey RS, McMurray JJV, Michaelson EL, Olofsson B, Ostergren J, Yusuf S. Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. Journal of Cardiac Failure. Elsevier BV; 2004. p. S76–S76.
Published In
Journal of Cardiac Failure
DOI
ISSN
1071-9164
Publication Date
August 2004
Volume
10
Issue
4
Start / End Page
S76 / S76
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology